ES2613537T3 - Procedimientos para identificar y diferenciar componentes víricos de vacunas multivalentes contra la fiebre del transporte - Google Patents

Procedimientos para identificar y diferenciar componentes víricos de vacunas multivalentes contra la fiebre del transporte Download PDF

Info

Publication number
ES2613537T3
ES2613537T3 ES11813620.9T ES11813620T ES2613537T3 ES 2613537 T3 ES2613537 T3 ES 2613537T3 ES 11813620 T ES11813620 T ES 11813620T ES 2613537 T3 ES2613537 T3 ES 2613537T3
Authority
ES
Spain
Prior art keywords
virus
specific
bvdv1b
amplification primer
nucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11813620.9T
Other languages
English (en)
Inventor
Dale Wade WEISE
James Robert HARRIS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2613537T3 publication Critical patent/ES2613537T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Un procedimiento para detectar la presencia de un virus BVDV1b (virus de la diarrea vírica bovina de tipo 1b) vivo, en el que el procedimiento comprende detectar un polinucleótido específico de BVDV1b en una población de polinucleótidos obtenida de una pluralidad de partículas de virus contenidas en una muestra mediante las siguientes etapas: (A) Diluir la muestra en (i) una placa de ensayo que contenga células bovinas cultivadas, en la que las partículas de virus puedan replicarse y (ii) una placa de referencia sin células; (B) Realizar al menos una etapa de ciclado de una reacción en cadena de polimerasa cuantitativa en tiempo real en la placa de ensayo y en la placa de referencia, usando una composición que comprenda un primer cebador de amplificación oligonucleotídico específico de virus de menos de 50 nucleótidos de longitud que comprenda una secuencia de nucleótidos de SEQ ID NO: 1, un segundo cebador de amplificación oligonucleotídico específico de virus de menos de 50 nucleótidos de longitud que comprenda una secuencia de nucleótidos de SEQ ID NO: 2 y al menos una primera sonda de detección marcada, específica de virus, de menos de 50 nucleótidos de longitud que comprenda una secuencia de nucleótidos marcada de SEQ ID NO: 3, en el que el primer cebador de amplificación y el segundo cebador de amplificación producen un producto de amplificación específico de virus, en el que el producto de amplificación así producido se pone en contacto con al menos la primera sonda de detección marcada, en condiciones eficaces para detectar específicamente el producto de hibridación resultante, y en el que la detección del producto de hibridación resultante en la placa de ensayo, a un nivel más alto en comparación con el de la placa de referencia, indica la presencia del polinucleótido específico de BVDV1b de un virus BVDV1b vivo.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15
imagen16
imagen17
imagen18
imagen19
imagen20
imagen21
imagen22
imagen23
imagen24

Claims (1)

  1. imagen1
ES11813620.9T 2010-12-27 2011-12-21 Procedimientos para identificar y diferenciar componentes víricos de vacunas multivalentes contra la fiebre del transporte Active ES2613537T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061427404P 2010-12-27 2010-12-27
US201061427404P 2010-12-27
PCT/US2011/066392 WO2012092054A2 (en) 2010-12-27 2011-12-21 Compositions and methods for identifying and differentiating viral components of multivalent shipping fever vaccines

Publications (1)

Publication Number Publication Date
ES2613537T3 true ES2613537T3 (es) 2017-05-24

Family

ID=45532015

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11813620.9T Active ES2613537T3 (es) 2010-12-27 2011-12-21 Procedimientos para identificar y diferenciar componentes víricos de vacunas multivalentes contra la fiebre del transporte

Country Status (15)

Country Link
US (1) US9238843B2 (es)
EP (1) EP2659007B1 (es)
JP (1) JP6027023B2 (es)
CN (1) CN103403191B (es)
AR (1) AR084358A1 (es)
AU (1) AU2011352801B2 (es)
BR (1) BR112013016467A2 (es)
CA (1) CA2822798C (es)
ES (1) ES2613537T3 (es)
MX (1) MX348307B (es)
NZ (1) NZ611657A (es)
PL (1) PL2659007T3 (es)
PT (1) PT2659007T (es)
TW (1) TWI513821B (es)
WO (1) WO2012092054A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019514429A (ja) * 2016-05-06 2019-06-06 プロビナンス バイオファブリックス インコーポレイテッド 培養レザー及びこれを用いて作製された製品
CN106906307A (zh) * 2017-03-10 2017-06-30 中国农业科学院特产研究所 牛副流感病毒3型病毒nano‑PCR检测试剂盒及其制备方法
CN113913461A (zh) * 2021-11-15 2022-01-11 贵州大学 牛病毒性腹泻e0-e2基因重组腺病毒疫苗构建方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
DE3329892A1 (de) 1983-08-18 1985-03-07 Köster, Hubert, Prof. Dr., 2000 Hamburg Verfahren zur herstellung von oligonucleotiden
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
FR2596761B1 (fr) 1986-04-08 1988-05-20 Commissariat Energie Atomique Derives de nucleosides et leur utilisation pour la synthese d'oligonucleotides
US4992051A (en) * 1987-11-03 1991-02-12 Novagene, Inc. Infectious bovine rhinotracheitis virus mutants, methods for the production of same and methods for the use of same
US5491225A (en) 1991-12-19 1996-02-13 Hoffmann-La Roche Inc. PCR primers for detection of legionella species and methods for controlling visual intensity in hybridization assays
US5279721A (en) 1993-04-22 1994-01-18 Peter Schmid Apparatus and method for an automated electrophoresis system
CA2189979C (en) 1994-05-10 2011-04-19 Hsien-Jue Chu Improved modified live brsv vaccine
FR2751229B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
EP1104676A1 (en) 1999-11-30 2001-06-06 Boehringer Ingelheim Vetmedica Gmbh Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
US20060084052A1 (en) * 2001-03-27 2006-04-20 Smithkline Beecham Corp. Detection of viable agents
ATE437223T1 (de) * 2000-06-23 2009-08-15 Intervet Int Bv Attenuiertes bovines respiratorisches syncytialvirus
EP2145965A1 (en) * 2000-10-18 2010-01-20 Pharmasset, Inc. Multiplex quantification of nucleic acids in diseased cells
BR0318114B1 (pt) * 2003-02-19 2014-09-02 Merial Ltd Vacinação ou imunização utilizando um regime de iniciação-reforço
WO2005089793A1 (en) 2004-03-17 2005-09-29 Pharmacia & Upjohn Company Llc Method of vaccination against testicular bvdv infection
UY29915A1 (es) 2005-11-15 2007-06-29 Boehringer Ingelheim Vetmed Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina
EP2026839A4 (en) 2005-12-14 2009-04-01 Univ Oklahoma RNA VIRUS VACCINE AND METHODS
US8354514B2 (en) * 2007-01-12 2013-01-15 Lawrence Livermore National Security, Llc Multiplex detection of agricultural pathogens
CN101696453B (zh) * 2009-11-02 2012-01-25 东北农业大学 检测牛病毒性腹泻病毒逆转录环介导等温扩增反应试剂盒的制备方法
PT2658570T (pt) * 2010-12-27 2019-02-08 Elanco Us Inc Composições e métodos vacinais contra o vírus da diarreia viral bovina tipo 1b

Also Published As

Publication number Publication date
US9238843B2 (en) 2016-01-19
MX348307B (es) 2017-06-06
CN103403191B (zh) 2016-05-18
AU2011352801A1 (en) 2013-06-27
BR112013016467A2 (pt) 2018-09-18
MX2013007586A (es) 2013-10-17
CN103403191A (zh) 2013-11-20
WO2012092054A2 (en) 2012-07-05
CA2822798C (en) 2016-11-01
PL2659007T3 (pl) 2017-08-31
EP2659007B1 (en) 2016-11-16
AU2011352801B2 (en) 2015-05-21
JP2014502846A (ja) 2014-02-06
NZ611657A (en) 2015-04-24
WO2012092054A3 (en) 2012-12-27
PT2659007T (pt) 2017-01-18
US20130266934A1 (en) 2013-10-10
TWI513821B (zh) 2015-12-21
CA2822798A1 (en) 2012-07-05
AR084358A1 (es) 2013-05-08
JP6027023B2 (ja) 2016-11-16
TW201307571A (zh) 2013-02-16
EP2659007A2 (en) 2013-11-06

Similar Documents

Publication Publication Date Title
Emerson et al. Schrödinger’s microbes: tools for distinguishing the living from the dead in microbial ecosystems
Forbes et al. Metagenomics: the next culture-independent game changer
Hoffmann et al. A review of RT-PCR technologies used in veterinary virology and disease control: sensitive and specific diagnosis of five livestock diseases notifiable to the World Organisation for Animal Health
Belák Molecular diagnosis of viral diseases, present trends and future aspects: A view from the OIE Collaborating Centre for the Application of Polymerase Chain Reaction Methods for Diagnosis of Viral Diseases in Veterinary Medicine
Bunke et al. High genetic diversity of porcine enterovirus G in Schleswig-Holstein, Germany
Cho et al. Evaluation of the AdvanSure™ real-time RT-PCR compared with culture and Seeplex RV15 for simultaneous detection of respiratory viruses
JP2017518768A5 (es)
van Rijn et al. Bluetongue virus serotype 6 in Europe in 2008—emergence and disappearance of an unexpected non-virulent BTV
Pérez et al. Development and validation of a novel SYBR Green real-time RT-PCR assay for the detection of classical swine fever virus evaluated on different real-time PCR platforms
ES2613537T3 (es) Procedimientos para identificar y diferenciar componentes víricos de vacunas multivalentes contra la fiebre del transporte
CN110551845A (zh) 一种用于检测传染性脾肾坏死病毒的数字pcr检测引物及试剂盒
JP2015533503A5 (es)
Ellerbrok et al. External quality assessment study for ebolavirus PCR-diagnostic promotes international preparedness during the 2014–2016 Ebola outbreak in West Africa
Ou et al. Droplet microfluidics on analysis of pathogenic microbes for wastewater-based epidemiology
CN106119417A (zh) 一种精确定量检测诺如病毒ⅰ型的试剂盒及检测方法
Xu et al. A one-tube rapid visual CRISPR assay for the field detection of Japanese encephalitis virus
Miller et al. Newcastle disease virus detection and differentiation from avian influenza
Dong et al. From the basics to emerging diagnostic technologies: What is on the horizon for tilapia disease diagnostics?
Mo et al. Validation of specific quantitative real-time RT-PCR assay panel for Infectious Bronchitis using synthetic DNA standards and clinical specimens
CN105368985A (zh) 对虾tsv和imnv荧光定量检测引物和探针及试剂盒
Yin et al. Visual detection of duck Tembusu virus with CRISPR/Cas13: A sensitive and specific point-of-care detection
Moscoso et al. Molecular analysis of infectious bursal disease virus from bursal tissues collected on FTA® filter paper
CN1865937A (zh) 同时检测a、b型流感病毒的实时荧光定量检测方法及试剂盒
Boutin et al. A fast, highly sensitive double‐nested PCR‐based method to screen fish immunobiomes
Maier et al. Evaluation of daphnid grazing on microscopic zoosporic fungi by using comparative threshold cycle quantitative PCR